These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29526023)

  • 1. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.
    Anderson RI; Moorman DE; Becker HC
    Handb Exp Pharmacol; 2018; 248():473-503. PubMed ID: 29526023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.
    Li Y; van den Pol AN
    J Neurosci; 2006 Dec; 26(50):13037-47. PubMed ID: 17167093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.
    Moorman DE
    Psychopharmacology (Berl); 2018 Jun; 235(6):1663-1680. PubMed ID: 29508004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the non-opioid dynorphin peptide des-Tyr-dynorphin (DYN-A(2-17)) in food intake and physical activity, and its interaction with orexin-A.
    Gac L; Butterick TA; Duffy CM; Teske JA; Perez-Leighton CE
    Peptides; 2016 Feb; 76():14-8. PubMed ID: 26654796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.
    James MH; Fragale JE; O'Connor SL; Zimmer BA; Aston-Jones G
    Neuropharmacology; 2021 Feb; 183():108359. PubMed ID: 33091458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
    Moorman DE; James MH; Kilroy EA; Aston-Jones G
    Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.
    Walker BM; Valdez GR; McLaughlin JP; Bakalkin G
    Alcohol; 2012 Jun; 46(4):359-70. PubMed ID: 22459870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors.
    Hopf FW
    Neuropharmacology; 2020 May; 168():108013. PubMed ID: 32092435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons.
    Ferrari LL; Park D; Zhu L; Palmer MR; Broadhurst RY; Arrigoni E
    J Neurosci; 2018 Feb; 38(6):1588-1599. PubMed ID: 29311142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S.
    Ubaldi M; Giordano A; Severi I; Li H; Kallupi M; de Guglielmo G; Ruggeri B; Stopponi S; Ciccocioppo R; Cannella N
    Biol Psychiatry; 2016 Mar; 79(6):452-62. PubMed ID: 26055195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
    Anderson RI; Becker HC
    Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin and its role in alcohol use disorder.
    Karkhanis AN; Al-Hasani R
    Brain Res; 2020 May; 1735():146742. PubMed ID: 32114059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic interactions between orexin and dynorphin may delay onset of functional orexin effects: a modeling study.
    Williams KS; Behn CG
    J Biol Rhythms; 2011 Apr; 26(2):171-81. PubMed ID: 21454297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.
    Jamensky NT; Gianoulakis C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1455-64. PubMed ID: 9394118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons.
    Eriksson KS; Sergeeva OA; Selbach O; Haas HL
    Eur J Neurosci; 2004 Mar; 19(5):1278-84. PubMed ID: 15016085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Orexins/Hypocretins in Alcohol Use and Abuse.
    Walker LC; Lawrence AJ
    Curr Top Behav Neurosci; 2017; 33():221-246. PubMed ID: 27909991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin (hypocretin) neurons contain dynorphin.
    Chou TC; Lee CE; Lu J; Elmquist JK; Hara J; Willie JT; Beuckmann CT; Chemelli RM; Sakurai T; Yanagisawa M; Saper CB; Scammell TE
    J Neurosci; 2001 Oct; 21(19):RC168. PubMed ID: 11567079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
    Bruchas MR; Land BB; Chavkin C
    Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of alcohol-seeking by orexin (hypocretin) neurons.
    Lawrence AJ
    Brain Res; 2010 Feb; 1314():124-9. PubMed ID: 19646424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.